scholarly article | Q13442814 |
P356 | DOI | 10.1111/1471-0528.14151 |
P698 | PubMed publication ID | 27297096 |
P50 | author | Jeff Keelan | Q40627515 |
P2093 | author name string | B W Mol | |
J Scaffidi | |||
P2860 | cites work | Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q26782024 |
Epidemiology of medications use in pregnancy | Q28083692 | ||
Market failure and the poverty of new drugs in maternal health | Q33316160 | ||
Designing drug trials: considerations for pregnant women | Q34999905 | ||
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention--convened meeting | Q35794981 | ||
Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006. | Q35891733 | ||
Management of prescription and nonprescription drug use during pregnancy | Q43250319 | ||
Incidence-based cost-of-illness model for metastatic breast cancer in the United States. | Q44244967 | ||
Prescription drug use in pregnancy. | Q44333289 | ||
How do we know if an exposure is actually teratogenic in humans? | Q44842468 | ||
The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008. | Q46320697 | ||
Drug labeling in the practice of obstetric anesthesia | Q47875215 | ||
The need for safer medication use in pregnancy | Q35926283 | ||
Medication Exposure in Pregnancy Risk Evaluation Program | Q35992364 | ||
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. | Q37222764 | ||
Obstetric Pharmacokinetic Dosing Studies are Urgently Needed | Q37575742 | ||
Evolving knowledge of the teratogenicity of medications in human pregnancy. | Q37902132 | ||
Exclusion of pregnant women from industry-sponsored clinical trials | Q38150667 | ||
Every Newborn: progress, priorities, and potential beyond survival | Q38213943 | ||
P433 | issue | 1 | |
P921 | main subject | human pregnancy | Q11995 |
pregnant person | Q104720811 | ||
P304 | page(s) | 132-140 | |
P577 | publication date | 2016-06-14 | |
P1433 | published in | BJOG: an International Journal of Obstetrics and Gynaecology | Q15724571 |
P1476 | title | The pregnant women as a drug orphan: a global survey of registered clinical trials of pharmacological interventions in pregnancy | |
P478 | volume | 124 |
Q90179305 | A review of clinical studies involving pregnant women registered in the Clinical Trials Registry of India |
Q52620795 | An advanced human in vitro co-culture model for translocation studies across the placental barrier. |
Q89565542 | Anatomical and physiological alterations of pregnancy |
Q91755110 | Antenatal sildenafil citrate treatment increases offspring blood pressure in the placental-specific Igf2 knockout mouse model of FGR |
Q49631079 | Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period |
Q56342051 | Beyond "Vessels and Vectors": A Global Review of Registered HIV-Related Clinical Trials with Pregnant Women |
Q47546991 | Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach |
Q93058456 | Including pregnant women in clinical research: time to overcome the barriers |
Q90142233 | Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards? |
Q61479716 | Liposomes as Gene Delivery Vectors for Human Placental Cells |
Q93090260 | Medicines in pregnancy |
Q54221187 | PregOMICS-Leveraging systems biology and bioinformatics for drug repurposing in maternal-child health. |
Q94459111 | Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic |
Q97543488 | The Pathway Forward: Insights on Factors that Facilitate Research with Pregnant Women |
Q99624399 | The challenge of using nanotherapy during pregnancy: Technological aspects and biomedical implications |
Q33760424 | Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance |